跳至主要内容
临床试验/CTRI/2017/09/009671
CTRI/2017/09/009671已完成4 期

To evaluate the treatment response and expression of hMLH1, MDM2 & p63 in oral potentially malignant disease.

Maulana Azad Institute Of Dental Sciences0 个研究点目标入组 45 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Clinically and histopathologically proven cases of OSMF
  • 1) Positive history of chewing areca nut or one of its commercial preparation, difficulty in swallowing and chewing, and burning sensation on eating spicy food.
  • 2) Restricted mouth opening and changes in the oral mucous membrane including the presence of vertical fibrous bands , stiffness and blanching.
  • 30 positive history of tobacco, smoking, betel quid and alcohol.

排除标准

  • 1) Those who were not willing to participate.
  • 2)Patients who were already undertaking some treatment for existing potentially malignant disorder.
  • 3)Patients with severe systemic disease.

研究者

相似试验